Sort by
Items per page

Send to

Choose Destination

Best matches for aspirin, heart attacks:

Search results

Items: 1 to 20 of 7849


Perioperative aspirin therapy in non-cardiac surgery: A systematic review and meta-analysis of randomized controlled trials.

Wolff G, Navarese EP, Brockmeyer M, Lin Y, Karathanos A, Kołodziejczak M, Kubica J, Polzin A, Zeus T, Westenfeld R, Andreotti F, Kelm M, Schulze V.

Int J Cardiol. 2018 May 1;258:59-67. doi: 10.1016/j.ijcard.2017.12.088. No abstract available.


6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial.

Hahn JY, Song YB, Oh JH, Cho DK, Lee JB, Doh JH, Kim SH, Jeong JO, Bae JH, Kim BO, Cho JH, Suh IW, Kim DI, Park HK, Park JS, Choi WG, Lee WS, Kim J, Choi KH, Park TK, Lee JM, Yang JH, Choi JH, Choi SH, Gwon HC; SMART-DATE investigators.

Lancet. 2018 Mar 9. pii: S0140-6736(18)30493-8. doi: 10.1016/S0140-6736(18)30493-8. [Epub ahead of print]


Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms.

De Stefano V, Carobbio A, Di Lazzaro V, Guglielmelli P, Iurlo A, Finazzi MC, Rumi E, Cervantes F, Elli EM, Randi ML, Griesshammer M, Palandri F, Bonifacio M, Hernandez-Boluda JC, Cacciola R, Miroslava P, Carli G, Beggiato E, Ellis MH, Musolino C, Gaidano G, Rapezzi D, Tieghi A, Lunghi F, Loscocco GG, Cattaneo D, Cortelezzi A, Betti S, Rossi E, Finazzi G, Censori B, Cazzola M, Bellini M, Arellano-Rodrigo E, Bertozzi I, Sadjadian P, Vianelli N, Scaffidi L, Gomez M, Cacciola E, Vannucchi AM, Barbui T.

Blood Cancer J. 2018 Feb 28;8(3):25. doi: 10.1038/s41408-018-0048-9.


Effectiveness of new antiplatelets in the prevention of recurrent myocardial infarction.

Grimaldi-Bensouda L, Danchin N, Dallongeville J, Falissard B, Furber A, Cottin Y, Bonello L, Morel O, Leclercq F, Puymirat E, Ghanem F, Delarche N, Benichou J, Abenhaim L; PGRx-Acute Coronary Syndrome Study Group.

Heart. 2018 Mar 13. pii: heartjnl-2017-312534. doi: 10.1136/heartjnl-2017-312534. [Epub ahead of print]


Third-Generation P2Y12 Inhibitors in East Asian Acute Myocardial Infarction Patients: A Nationwide Prospective Multicentre Study.

Kang J, Han JK, Ahn Y, Chae SC, Kim YJ, Chae IH, Hur SH, Seong IW, Chae JK, Cho MC, Seung KB, Jeong MH, Yang HM, Park KW, Kang HJ, Koo BK, Kim HS; investigators for Korea Acute Myocardial Infarction Registry-National Institute of Health (KAMIR-NIH).

Thromb Haemost. 2018 Mar;118(3):591-600. doi: 10.1055/s-0038-1626697. Epub 2018 Mar 13.


Improving the Prescribing Gap For Guideline Recommended Medications Post Myocardial Infarction.

Wilkins B, Hullikunte S, Simmonds M, Sasse A, Larsen PD, Harding SA.

Heart Lung Circ. 2017 Nov 14. pii: S1443-9506(17)31490-7. doi: 10.1016/j.hlc.2017.10.025. [Epub ahead of print]


Socioeconomic inequality in medication persistence in primary and secondary prevention of coronary heart disease - A population-wide electronic cohort study.

King W, Lacey A, White J, Farewell D, Dunstan F, Fone D.

PLoS One. 2018 Mar 9;13(3):e0194081. doi: 10.1371/journal.pone.0194081. eCollection 2018.


Impact of CYP2C19 polymorphism in prognosis of minor stroke or TIA patients with declined eGFR on dual antiplatelet therapy: CHANCE substudy.

Wu Y, Zhou Y, Pan Y, Zhao X, Liu L, Wang D, Wang C, Li H, Johnston SC, Meng X, Wang Y, Wang Y; CHANCE Investigators.

Pharmacogenomics J. 2018 Mar 8. doi: 10.1038/s41397-018-0018-4. [Epub ahead of print]


Aspirin Reduces Cardiac Interstitial Fibrosis by Inhibiting Erk1/2-Serpine2 and P-Akt Signalling Pathways.

Li X, Wang G, QiLi M, Liang H, Li T, E X, Feng Y, Zhang Y, Liu X, Qian M, Xu B, Shen Z, Gitau SC, Zhao D, Shan H.

Cell Physiol Biochem. 2018 Mar 2;45(5):1955-1965. doi: 10.1159/000487972. [Epub ahead of print]


Comparison of single versus dual antiplatelet therapy after TAVR: A systematic review and meta-analysis.

Raheja H, Garg A, Goel S, Banerjee K, Hollander G, Shani J, Mick S, White J, Krishnaswamy A, Kapadia S.

Catheter Cardiovasc Interv. 2018 Mar 8. doi: 10.1002/ccd.27582. [Epub ahead of print]


Platelet transfusion is not associated with increased mortality or morbidity in patients undergoing cardiac surgery.

Ninkovic S, McQuilten Z, Gotmaker R, Newcomb AE, Cole-Sinclair MF.

Transfusion. 2018 Mar 7. doi: 10.1111/trf.14561. [Epub ahead of print]


Multimorbidity and survival for patients with acute myocardial infarction in England and Wales: Latent class analysis of a nationwide population-based cohort.

Hall M, Dondo TB, Yan AT, Mamas MA, Timmis AD, Deanfield JE, Jernberg T, Hemingway H, Fox KAA, Gale CP.

PLoS Med. 2018 Mar 6;15(3):e1002501. doi: 10.1371/journal.pmed.1002501. eCollection 2018 Mar.


Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial.

Wangqin R, Wang X, Wang Y, Xian Y, Zhao X, Liu L, Li H, Meng X, Wang Y.

Stroke Vasc Neurol. 2017 Jul 6;2(4):176-183. doi: 10.1136/svn-2017-000088. eCollection 2017 Dec.


Influence of proton pump inhibitors on clinical outcomes in coronary heart disease patients receiving aspirin and clopidogrel: A meta-analysis.

Hu W, Tong J, Kuang X, Chen W, Liu Z.

Medicine (Baltimore). 2018 Jan;97(3):e9638. doi: 10.1097/MD.0000000000009638.


ADP Platelet Hyperreactivity Predicts Cardiovascular Disease in the FHS (Framingham Heart Study).

Puurunen MK, Hwang SJ, Larson MG, Vasan RS, O'Donnell CJ, Tofler G, Johnson AD.

J Am Heart Assoc. 2018 Mar 3;7(5). pii: e008522. doi: 10.1161/JAHA.118.008522.


Safety and Incidence of Cardiovascular Events in Chinese Patients with Acute Coronary Syndrome Treated with Ticagrelor: the 12-Month, Phase IV, Multicenter, Single-Arm DAYU Study.

Gao R, Wu Y, Liu H, Su G, Yuan Z, Zhang A, Wang Y, Wang Z, Wang Y, Zhang H, Zheng Y, Liu L, Shen L, Leonsson-Zachrisson M, Han Y; DAYU study investigators.

Cardiovasc Drugs Ther. 2018 Feb;32(1):47-56. doi: 10.1007/s10557-018-6772-3.


Evaluating the use of appropriate anticoagulation with lenalidomide and pomalidomide in patients with multiple myeloma.

Anderson SM, Beck B, Sterud S, Lockhorst R, Ngorsuraches S.

J Oncol Pharm Pract. 2018 Jan 1:1078155218758500. doi: 10.1177/1078155218758500. [Epub ahead of print]


[Cardiovascular Medication in Elderly Patients].

Schwinger RHG.

Dtsch Med Wochenschr. 2018 Feb;143(4):236-243. doi: 10.1055/s-0043-108475. Epub 2018 Feb 22. German.


Impaired aspirin-mediated platelet function inhibition in resuscitated patients with acute myocardial infarction treated with therapeutic hypothermia: a prospective, observational, non-randomized single-centre study.

Prüller F, Milke OL, Bis L, Fruhwald F, Scherr D, Eller P, Pätzold S, Altmanninger-Sock S, Rainer P, Siller-Matula J, von Lewinski D.

Ann Intensive Care. 2018 Feb 21;8(1):28. doi: 10.1186/s13613-018-0366-x.


Weighing the Anti-Ischemic Benefits and Bleeding Risks from Aspirin Therapy: a Rational Approach.

Dugani S, Ames JM, Manson JE, Mora S.

Curr Atheroscler Rep. 2018 Feb 21;20(3):15. doi: 10.1007/s11883-018-0717-y. Review.


Supplemental Content

Loading ...
Support Center